Sort
15,273 grants matching “antimicrobial resistance”
Beta-Lactamase Inhibitors Sensitize Multidrug-Resistant Gram-negative Pathogens to Innate Immune Clearance
$205,240Erlinda Rose Ulloa · University Of California-Irvine · K08 · FY2022 · AI
Institutional Training Grant in Pediatric Infectious Disease
$205,178Coleen K. Cunningham · Duke University · T32 · FY2013 · HD
Beta-Lactamase Inhibitors Sensitize Multidrug-Resistant Gram-negative Pathogens to Innate Immune Clearance
$205,176Erlinda Rose Ulloa · University Of California-Irvine · K08 · FY2023 · AI
STRUCTURAL STUDIES OF BACTERIAL HYALURONATE LYASE ENZYME
$205,133Children'S Hospital &Res Ctr At Oakland · R01 · FY2002 · AI
Beta-Lactamase Inhibitors Sensitize Multidrug-Resistant Gram-negative Pathogens to Innate Immune Clearance
$205,111Erlinda Rose Ulloa · University Of California-Irvine · K08 · FY2024 · AI
Molecular and Structural Bases of Polymyxin Resistance
$205,102Eduardo A. Groisman · Washington University · R01 · FY2008 · AI
Admin Core
$205,060David R Andes · University Of Wisconsin-Madison · U19 · FY2020 · AI
Exploring the role of metagenomic deep sequencing for trachoma
$205,000Jeremy David Keenan · University Of California, San Francisco · R21 · FY2025 · EY
Antimicrobial peptide mimetic activity against Candida auris
$205,000Gill Diamond · University Of Louisville · R21 · FY2021 · AI
Maltoheptaose based nanotherapeutics for multidrug resistant bacterial infection
$204,975Mingdi Yan · University Of Massachusetts Lowell · R21 · FY2014 · AI
Cloud-enabled genomics resource for automated pathogen diagnostics in the field
$204,880W. Florian Fricke · University Of Maryland Baltimore · R21 · FY2013 · AI
Task A16: In Vitro Assessment for Antimicrobial Activity
$204,867Thomas Patterson · University Of Texas Hlth Science Center · N01 · FY2015 · AI
Epidemiologic Methods: Resistant Nosocomial Infections
$204,844Harvard University (Sch Of Public Hlth) · R21 · FY2004 · AI
New composite material design based on studies of tooth-composite and microbial i
$204,711Yoav Finer · University Of Toronto · R01 · FY2012 · DE
Toxoplasma in the GI tract: Protective role of a parasite protease inhibitor
$204,688Isabelle Coppens · Johns Hopkins University · R21 · FY2021 · AI
Antibiotic Knowledge and Attitudes among Nursing Home Patients, Family and Staff.
$204,688Jonathan M Zenilman · Johns Hopkins University · R21 · FY2020 · AG
S. aureus virulence factor expression during kidney abscess formation
$204,688Kim Davis · Johns Hopkins University · R21 · FY2023 · AI
Evaluation of PARP-1 as a target of host-directed therapy in tuberculosis
$204,687William Ramses Bishai · Johns Hopkins University · R21 · FY2019 · AI
Targeting host immune cells and DAMP molecules to improve outcome in tuberculosis
$204,687William Ramses Bishai · Johns Hopkins University · R21 · FY2019 · AI
Core 3 Math Modeling Core
$204,650Michael N. Neely · University Of Florida · P01 · FY2024 · AI
Harnessing inflammasome activation to enhance efficacy of Salmonella vaccines
$204,648Igor E Brodsky · University Of Pennsylvania · R21 · FY2016 · AI
The development of multiplexed, label-free isothermal diagnostic for rapid identification of bacterial pathogens
$204,625Irina Smolina · Boston University (Charles River Campus) · R21 · FY2016 · AI
Mouse Models of Pediatric Osteomyelitis
$204,600Deborah V Novack · Washington University · R21 · FY2018 · AR
Deficiency of Short-Chain Fatty Acids in Acne Vulgaris
$204,600Chun-Ming Huang · University Of California, San Diego · R21 · FY2017 · AR
Probiotic Skin Microbiome for Acne Vulgaris
$204,600Chun-Ming Huang · University Of California, San Diego · R21 · FY2016 · AR